Business Type Exporter, Retailer
Location suzhou
Year Established 2001
Main Markets South America 8% Africa 10% Eastern Asia 8% Domestic Market 12% North America 10% Eastern Europe 8% Southern Europe 8% Mid East 12% Northern Europe 8% Oceania 16%
Main Products Entecavir,Posaconazole,Pemetrexed,Aliskiren,Argatroban,Alvimopan,Anidulafungin,Aprepitant,Boceprevir,Bortezomib,Caspofungin,Cladribine,Decitabine,Dronedarone,Fondaparinux,Latamoxef,Oseltamivir,Pneumocandin B0,Saxagliptin,Sitagliptin,Te,
Country/Region China
Company Introduction
The Bright-Gene is a fast-growing biopharmaceutical company that engages in the research, development and manufacturing of Active Pharmaceutical Ingredients and Intermediates with primary focus on the high-end API market and late-stage drug candidates. we established in 2001, In 2008, its turnover reached $5, 000, 000, and 90% of the products were exported to overseas. the Bright-gene always cares about quality management system. The eight drugs of our company have had the GMP certificates of SFDA, and the product quality meet the standards of the national pharmacopoeia in China, America, England and Japan.we have perfect quality system on product progress, now we have one R&D centre and three workshop which produce the entecavir, Dasatinib and Posaconazole separately.
Contact Information
Contact Person Mr. Kevin Wan
Department Manager
Telephone 86-512-62956044
Fax Number 86-512-62956044
Address xinghu, suzhou, jiangsu, China
Fax 86-512-62956044
Zip/Post Code 215011
Website Visit website